Specialty crop input producer Verdesian Life Sciences, Cary, N.C., announced on April 16 that it has acquired Cytozyme Laboratories Inc., Salt Lake City.
“This acquisition is a tremendous sign, not just for Verdesian Life Sciences, but for the category of nutrient use efficiency products,” said Verdesian CEO Kenny Avery. “For the past three years we have worked side by side with Cytozyme leadership as we partnered on Crop+, Seed+, and Seed+ Graphite technologies – products that have filled needs across agriculture and that have been embraced by the market. This partnership ensures that Verdesian will continue to innovate for the betterment of farmers everywhere. The knowledge and experience that Cytozyme brings to global agriculture is a tremendous asset as well.”
“For more than four decades, Cytozyme’s mission has been to help farmers achieve sustainable yields through innovative solutions,” said Cytozyme CEO Eric Baughman. “We firmly believe that Verdesian Life Sciences has the technology, capabilities, and the people to continue that mission in a way that is true to our ideals. Our two companies’ product mixes are incredibly complementary; this is a great day for growers everywhere.”
Since its start in 2012, Verdesian has grown its nutrient use efficiency technologies with the addition of products such as Avail, NutriSphere-N®, NUE-Charge G, Take Off LS, MicroSync products, Primacy Alpha, Nutri-Phite®, and Primo R1.
“This acquisition is part of Verdesian’s broader merger and acquisition growth strategy toward maintaining leadership across the nutrient use efficiency space,” said Rick Riegner, Verdesian Executive Vice President of Strategy & Business Development, “and it is further evidence of the continued embrace of products that offer sustainable solutions to farmers.”